1) Ott S. Metabolic bone diseases. In: Schumacher Jr, editor. Primer on the Rheumatic Diseases. Arthritis Found. Atlanta; 1993. p. 290-3.

2) Hench P S, Kendall E C, Slocumb C H, Polley H F. Effects of cortisone acetate and pituitary ACTH on Rheumatoid Arthritis, Rheumatic fever and certain other conditions. Arch Intern Med 1950; 85: 545-666.

3) Delezé M H, Morales J T, Jara L J. Osteoporosis inducida por corticoides: Patogenia, prevención y tratamiento. Tema de Revisión. Rev Peru Reum 1996; 2(2): 69-76.

4) Behrens TW, Goodwin JS. Glucocorticoids. In: Mc Carty. Arthritis and allied conditions.

5) Boumpas DT, Chrousos G P, Wilder R L, Cupps T R, Balow J E. Glucocorticoid Therapy for Immune-Mediated Diseases: Basic and Clinical Correlates. [NIH Conference]. Ann Intern Med 1993; 119(12): 1198-208.

6) Vidal L, Martínez J. Osteoporosis. En: Vidal y cols. Bases y Principios de Reumatología. Lima; 1993. p 283-98.

7) Saag KG, Koehnke R, Caldwell J R, Brasington R, Burmeister L F, Zimmerman B, et al. Low dose-long term corticosteroid therapy in Rheumatoid Arthritis: An analisis of serious adverse events. Am J Med 1994; 96(2): 115-23.

8) Hannahs B. Metabolic and joint diseases. In: Koopman WJ. Arthritis and allied condition Volumen II. 13th Edition. 1997.

9) Hall G M, Spector T D, Griffin A J, Jawad A S, Hall M L, Doyle D V. The effect of rheumatoid arthritis and steroid therapy on bone density in postmenopausal women. Arthritis Rheum 1993; 36(11): 1510-6.

10) Lukert B P, Raisz L G. Glucocorticoid-Induced Osteoporosis: Pathogenesis and Management. Ann Intern Med 1990; 112: 352-64.

11) Becerra F. Osteoporosis inducida por corticoides. Bol Soc Per Med Int 1996; 9(1): 20-4.

12) Nuti R, Martiní G. Effects of Age and Menopause on Bone Density of Entire Skeleton in Healthy and Osteoporotic Women. Osteoporosis Int 1993; 3: 59-65.

13) Chavessieux P, Pastoureau P et al. Glucocorticoid Induced Inhibition of Osteoblastic Bone Formation in Ewes: A Biochemical and Histomorphometric Study. Osteoporosis Int 1993; 3: 97-102.

14) Acevedo E M. Osteoporosis. Rev Med IPSS 1994; 3(2): 41-50.

15) Reid I R, Heap S W. Determinants of Vertebral Mineral Density in Patients Receiving Long-term Glucocorticoid Therapy. Arch Intern Med 1990; 150: 2545-8.

16) Lindsay R. Prevention of osteoporosis. In: Favus MJ, ed. Primer on the metabolic bone diseases and disorders of mineral metabolism. Second Edition. Lippincott-Raven Publishers Philadelphia. New York, 1993.

17) Sambrook P N, Spector T D, Seeman E, Bellamy N, Buchanan R R, Duffy D L, et al. Osteoporosis in Rheumatoid Arthritis. A monozygotic Co-twin Control Study. Arthritis Rheum 1995; 38(6): 806-9.

18) Deohdar A A, Brabyn J, Jones P W, Davis M J, Woolf A D. Longitudinal Study of Hand Bone Densitometry in Rheumatoid Arthritis. Arthritis Rheum 1995; 38(9): 1204-10.

19) VanSchaardenburg D, Valkema R, Dijkmans B A, Papapoulos S, Zwinderman A H, Han K H, et al. Prednisone Treatment of Elderly-Onset Rheumatoid Arthritis. Arthritis Rheum 1995; 38(3): 334-42.

20) Laan R F, Buijs W C. Bone mineral density in patients with recent onset rheumatoid arthritis: influence of disease activity and functional capacity. Ann Rheum Dis 1993; 52: 21-6.

21) Reid I R. Steroid Osteoporosis. Osteoporosis Int 1993; (Suppl.1): S144-6.

22) Emkey R D, Lindsay R, Lyssy J, Weisbrg J S, Dempster D W, Shen V. The systemic effect of intraarticular administration of corticosteroid on markers of bone formation and bone resorption in patients with Rheumatoid Arthritis. Arthritis Rheum 1996; 39: 277-82.

23) Jergas M, Genant H K. Current methods and recent advances in the diagnosis of osteoporosis. Arthritis Rheum. 1993; 36: 1649-62.

24) Hagiwara S, Yang S O, Gluer C C, Bendavid E, Genant H. Noninvasive bone mineral density measurement in the evaluation of osteoporosis. Rheumatic Dis Clin NA 1994; 20: 651-69.

25) Genant H K, Faulkner K G, Gluer C C, Engelke K. Bone densitometry: Current Assessment. Osteoporosis Int 1993; (Suppl 1): 141-3.

26) Morita R, Orimo H, Yamamoto I. Some Problems of Dual-Energy X-ray Absorptiometry in the Clinical Use. Osteoporosis Int 1993; (Suppl 1): S87-90.

27) Johnston C C, Melton J. Bone density measurement and the management of osteoporosis. In: Favus MJ, ed. Primer on the metabolic bone diseases and disorders of mineral metabolism. Second Edition. Lippincott-Raven Publishers Philadelphia. New York, 1993.

28) Sambrook P, Birmingham J, Kelly P, Kempler S, Nguyen T, Pocock N, et al. Prevention of Corticosteroid Osteoporosis: A comparison of calcium, calcitriol and calcitonin. N Engl J Med 1993; 328(24): 1747-52.

29) Butler B R, Davie M W, Worsfold M. Bone mineral content in patients with Rheumatoid Arthritis: relationship to low-dose steroid therapy. Br J Rheumatology 1991; 30: 86-90.

30) Reid B D, Kennedy S J, Smith M A. Bone loss in Rheumatoid Arthritis and Primary Generalized Osteoarthrosis: Effects of Corticosteroids, Supressive Antirheumatic Drugs and Calcium Supplements. Br J Rheumatology 1986; 25: 253-9.

31) Leboff M S, Wade J P, Mackowiak S. Low Dose Prednisone Does Not Affect Calcium Homeostasis of Bone Density in Postmenopausal Women with Rheumatoid Arthritis. J Rheumatology 1991; 18: 3.

32) Glave C, Segami MI, Ugarte C et al. Validación multicéntrica inicial de la versión peruana del índice de incapacidad funcional (Health Assessment Questionaire-HAQ). Anales de la Facultad de Medicina 1996; 57(3): 174-8.

Regresar